Try our Advanced Search for more refined results

Expert Analysis

Hatch-Waxman Safe Harbor: Post-Approval Activity Update

Law360, New York (August 22, 2012, 3:50 PM EDT) -- The U.S. Supreme Court has twice addressed the scope of the safe harbor provision of the Hatch-Waxman Act (Eli Lilly & Co. v. Medtronic Inc., 496 U.S. 661 (1990) and Merck KGaA v. Integra Lifesciences, Ltd., 545 U.S. 193 (2005)), and has recently again expressed interest in this provision, requesting the solicitor general's input in connection with a petition for a writ of certiorari from the Federal Circuit case, Classen Immunotherapies Inc. v. Biogen IDEC, 659 F.3d 1057 (Fed. Cir. 2011)....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!